Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 32, 2021 - Issue 2
Submit an article Journal homepage
472
Views
13
CrossRef citations to date
0
Altmetric
Review Articles

Difference in vasoconstrictors: oxymetazoline vs. brimonidine

Nwanneka Okwundua Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, NC, USACorrespondence[email protected]
,
Abigail Clinea Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, NC, USA
&
Steven R. Feldmana Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, NC, USA;b Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA;c Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USAORCID Iconhttps://orcid.org/0000-0002-0090-6289
ORCID Icon
Pages 137-143 | Received 09 May 2019, Accepted 16 Jun 2019, Published online: 12 Aug 2019

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Federica Dall’Oglio, Maria Rita Nasca, Carlo Gerbino & Giuseppe Micali. (2022) Advances in pharmacotherapy for rosacea: what is the current state of the art?. Expert Opinion on Pharmacotherapy 23:16, pages 1845-1854.
Read now
Jihei Sara Lee & Chan Yun Kim. (2022) Brimonidine tartrate ophthalmic solution 0.025% for redness relief: an overview of safety and efficacy. Expert Review of Clinical Pharmacology 15:8, pages 911-919.
Read now
Federica Dall’Oglio, Maria Rita Nasca & Giuseppe Micali. (2021) Emerging topical drugs for the treatment of rosacea. Expert Opinion on Emerging Drugs 26:1, pages 27-38.
Read now

Articles from other publishers (10)

Fei Liu, Qiujun Zhou, Hui Wang, Hongyang Fu, Yuanyuan Li, Maocan Tao, Hongbin Luo & Yi Cao. (2023) Efficacy and safety of oxymetazoline for the treatment of rosacea: A meta‐analysis. Journal of Cosmetic Dermatology 22:9, pages 2408-2419.
Crossref
Chanudda Washrawirul, Thanaporn Puaratana‐arunkon, Yuda Chongpison, Nopadon Noppakun, Pravit Asawanonda & Chanat Kumtornrut. (2023) The role of the topical nasal decongestant oxymetazoline as a novel therapeutic option for post‐acne erythema: A split‐face, double‐blind, randomized, placebo‐controlled trial. The Journal of Dermatology 50:6, pages 739-745.
Crossref
Ben Wang, Yingxue Huang, Yan Tang, Zhixiang Zhao, Wei Shi, Dan Jian, Fangfen Liu, Qiong Gao, Peiru Wang, Jie Yang, Lin Li, Hongfu Xie & Ji Li. (2023) Paroxetine is an effective treatment for refractory erythema of rosacea: Primary results from the Prospective Rosacea Refractory Erythema Randomized Clinical Trial. Journal of the American Academy of Dermatology 88:6, pages 1300-1307.
Crossref
莉 涂. (2023) Progression of Local Treatment of Post-Acne Erythema. Advances in Clinical Medicine 13:06, pages 9188-9193.
Crossref
Richard G. W. Proudman, Juliana Akinaga & Jillian G. Baker. (2022) The signaling and selectivity of α‐adrenoceptor agonists for the human α2A , α2B and α2C ‐adrenoceptors and comparison with human α1 and β‐adrenoceptors . Pharmacology Research & Perspectives 10:5.
Crossref
Yun Wang, Shu-Ping Guo, Jun Cao & Ling Ren. (2022) Advances in the Treatment of Rosacea-Associated Facial Erythema. International Journal of Dermatology and Venereology 5:3, pages 149-154.
Crossref
B. Cribier. (2022) Rosacea: Treatment targets based on new physiopathology data. Annales de Dermatologie et de Vénéréologie 149:2, pages 99-107.
Crossref
Joseph Bikowski & Zoe Diana Draelos. 2022. Cosmetic Dermatology. Cosmetic Dermatology 598 605 .
Jerry Tsai, Anna L. Chien, Noori Kim, Saleh Rachidi, Brian M. Connolly, Hester Lim, Sabrina Sisto Alessi César, Sewon Kang & Luis A. Garza. (2021) Topical timolol 0.5% gel-forming solution for erythema in rosacea: A quantitative, split-face, randomized, and rater-masked pilot clinical trial. Journal of the American Academy of Dermatology 85:4, pages 1044-1046.
Crossref
Yusha Chen, Sushmita Pradhan & Siliang Xue. (2021) Topical brimonidine for pyogenic granuloma after paronychia surgery. JAAD Case Reports 7, pages 41-43.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.